Global Minimally Invasive Imaging Industry to 2027 –

Dublin, 12 July 2022 (GLOBE NEWSWIRE) — The “Minimally Invasive Imaging Market – Forecast 2022 to 2027” report has been added to from offer.

The global minimally invasive imaging market is booming due to technological advancements in medical devices resulting in greater efficiency, faster disease detection times, improved diagnostic processes and greater productivity in patient follow-up, combined with factors such as autoclaving regulations, growing demand for minimally invasive medical imaging systems, and increasing cases of chronic disorders.

Furthermore, increasing investments in the healthcare sector by both public and private entities, along with a growing tendency to take early action for disease prevention as a step towards preventative healthcare, will propel the market .

The market is driven by the growing prevalence of chronic diseases and increasing geriatric population. With age, the risk of falling ill increases accordingly. Nearly 80% of older adults in the United States have at least one chronic condition, according to the Centers for Disease Control and Prevention. Additionally, the American Medical Association predicts that by 2030, at least 60% of people age 65 and older will have more than one chronic condition.

According to the National Brain Tumor Society, 700,000 people in the United States will be living with a brain tumor in 2020, and another 87,000 are expected to be diagnosed. The prevalence of age-related disorders such as Alzheimer’s disease, arthritis, Parkinson’s disease, dementia, cancer, as well as cardiovascular disease is expected to increase as the world’s geriatric population grows. The demand for new treatment options, better healthcare facilities and medicines will increase as the population ages.

High cost of minimally invasive imaging systems, scarcity of skilled technicians, and strict government policies for complex testing regimes are major factors limiting the market for minimally invasive imaging systems. Additionally, due to certain technical limitations associated with solitary imaging modalities, researchers are reluctant to purchase them, which limits their market expansion. For example, CT scans show poor soft tissue contrast; therefore, it provides less information about functional qualities and exposes doctors and patients to radiation.

Key developments

Siemens Healthineers launched the Acuson Redwood ultrasound system in October 2019, providing an imaging solution for clinical departments such as radiology, cardiology and gynecology. The introduction of Al-compatible equipment is expected to drive demand, leading to market expansion. Allengers unveiled the first 32-slice CT scanner produced in India in January 2020 with help from Canon Medical Systems. Samsung NeuroLogica increased manufacturing of its 32-slice CT scanner, BodyTom mobile, in February 2020.

By system, the global minimally invasive imaging market can be segmented into ultrasound, CT scan, X-ray, MRI and others.

The X-ray sector is expected to dominate the global minimally invasive imaging industry due to the increasing use of direct radiography. The ultrasound segment is also expected to grow over the projected period.

By end users, the global minimally invasive imaging market can be segmented into diagnostic centers, hospitals and others including specialty clinics and research centers.

The hospital segment is expected to account for the largest share. Due to increased demand for medical imaging modalities such as MRI systems and CT scanners in hospital settings for accurate diagnosis during procedures, this will help propel the market forward. Additionally, hospitals are well equipped with medical imaging technology and skilled health experts to properly treat and diagnose patients’ body parts.

By geography, the global minimally invasive imaging market can be segmented into Asia-Pacific, North America, Middle East & Africa, South America, and Europe.

During the projected period, North America is expected to hold a large market share owing to improved healthcare infrastructure and increased R&D investment in the healthcare sector, as well as increasing measures of the US government to update the health care system. The Asia-Pacific region is expected to witness rapid growth owing to the development of medical tourism in Asia-Pacific countries such as India and the growing geriatric population in the region.

Information on COVID-19

During the outbreak, demand for MRI and molecular imaging equipment declined. During the first quarter of 2020, key companies such as GE, Philips and Siemens saw a drop in demand for these modalities. Another factor is new recommendations advised by radiology departments to reduce cross-sectional imaging, interventional radiology and ultrasound to prevent transmission of COVID-19 to staff and patients due to the COVID-19 pandemic. influencing the market.

However, due to several studies demonstrating the clinical effectiveness of X-rays in diagnosing patients with COVID-19 through chest CT scans, digital X-rays and CT scans are in high demand. Market companies have increased production of these modalities in response to growing demand, attempting to fill the imbalance between supply and demand. For example, according to Koninklijke Philips NV’s first quarter results during the outbreak, the company saw an increase in demand for X-ray and CT scan equipment. The company has increased its production of medical imaging equipment.

Main topics covered:




4.1. Market factors
4.2. Market constraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining power of suppliers
4.3.2. Bargaining powers of buyers
4.3.3. The threat of substitutes
4.3.4. The threat of new entrants
4.3.5. Competitive rivalry in the industry
4.4. Industry Value Chain Analysis

5.1. Introduction
5.2. Organ preservation solutions
5.3. Transplant diagnosis
5.4. Tissue paper products
5.5. Others

6.1. Introduction
6.2. Hospitals
6.3. Diagnostic centers
6.4. Others

7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. Israel
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. Japan
7.6.3. India
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Taiwan
7.6.8. Others

8.1. Key Players and Strategic Analysis
8.2. Emerging players and market profitability
8.3. Mergers, acquisitions, agreements and collaborations
8.4. Supplier Competitiveness Matrix

9.1. Hitachi Medical Systems
9.2. GE Healthcare
9.3. Boston Scientific Society
9.4. Medtronic plc
9.5. Koninklijke Philips NV
9.6. Canon Medical Systems Corporation
9.7. Carestream Health
9.8. Trivitron Health
9.9. FUJIFILM Company.
9.10. B. Braun Melsungen AG
9.11. Siemens Healthineers

For more information on this report visit

  • Global Minimally Invasive Imaging Market